Siegbert Rieg

InstitutionUniversitätsklinikum Freiburg
AddressGermany
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 21 Covid-19 publications, with a maximum of 4 publications in November 2020
    All Publications
    Bar chart showing 81 publications over 18 distinct years, with a maximum of 11 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Greinacher A, Selleng K, Mayerle J, Palankar R, Wesche J, Reiche S, Aebischer A, Warkentin TE, Muenchhoff M, Hellmuth JC, Keppler OT, Duerschmied D, Lother A, Rieg S, Gawaz MP, Mueller KAL, Scheer CS, Napp M, Hahnenkamp K, Lucchese G, Vogelgesang A, Flöel A, Lovreglio P, Stufano A, Marschalek R, Thiele T. Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein. Blood. 2021 10 07; 138(14):1269-1277. PMID: 34280256.
      Citations: 17     Fields:    Translation:HumansCells
    2. Kleineberg NN, Knauss S, Gülke E, Pinnschmidt HO, Jakob CEM, Lingor P, Hellwig K, Berthele A, Höglinger G, Fink GR, Endres M, Gerloff C, Klein C, Stecher M, Classen AY, Rieg S, Borgmann S, Hanses F, Rüthrich MM, Hower M, Tometten L, Haselberger M, Piepel C, Merle U, Dolff S, Degenhardt C, Jensen BO, Vehreschild MJGT, Erber J, Franke C, Warnke C. Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS). Eur J Neurol. 2021 12; 28(12):3925-3937. PMID: 34411383.
      Citations: 2     Fields:    Translation:Humans
    3. August D, Stete K, Hilger H, Götz V, Biever P, Hosp J, Wagner D, Köhler TC, Gerstacker K, Seufert J, Laubner K, Kern W, Rieg S. [Complaints and clinical findings six months after COVID-19: outpatient follow-up at the University Medical Center Freiburg]. Dtsch Med Wochenschr. 2021 Sep; 146(17):e65-e73. PMID: 34425627.
      Citations:    Fields:    Translation:Humans
    4. Werfel S, Jakob CEM, Borgmann S, Schneider J, Spinner C, Schons M, Hower M, Wille K, Haselberger M, Heuzeroth H, Rüthrich MM, Dolff S, Kessel J, Heemann U, Vehreschild JJ, Rieg S, Schmaderer C. Development and validation of a simplified risk score for the prediction of critical COVID-19 illness in newly diagnosed patients. J Med Virol. 2021 12; 93(12):6703-6713. PMID: 34331717.
      Citations: 1     Fields:    Translation:Humans
    5. Citations: 22     Fields:    Translation:HumansCellsPHPublic Health
    6. Jakob CEM, Mahajan UM, Oswald M, Stecher M, Schons M, Mayerle J, Rieg S, Pletz M, Merle U, Wille K, Borgmann S, Spinner CD, Dolff S, Scherer C, Pilgram L, Rüthrich M, Hanses F, Hower M, Strauß R, Massberg S, Er AG, Jung N, Vehreschild JJ, Stubbe H, Tometten L, König R. Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning. Infection. 2021 Jul 19. PMID: 34279815.
      Citations: 4     Fields:    
    7. Klann JG, Estiri H, Weber GM, Moal B, Avillach P, Hong C, Tan ALM, Beaulieu-Jones BK, Castro V, Maulhardt T, Geva A, Malovini A, South AM, Visweswaran S, Morris M, Samayamuthu MJ, Omenn GS, Ngiam KY, Mandl KD, Boeker M, Olson KL, Mowery DL, Follett RW, Hanauer DA, Bellazzi R, Moore JH, Loh NW, Bell DS, Wagholikar KB, Chiovato L, Tibollo V, Rieg S, Li ALLJ, Jouhet V, Schriver E, Xia Z, Hutch M, Luo Y, Kohane IS, Brat GA, Murphy SN. Validation of an internationally derived patient severity phenotype to support COVID-19 analytics from electronic health record data. J Am Med Inform Assoc. 2021 07 14; 28(7):1411-1420. PMID: 33566082.
      Citations: 7     Fields:    Translation:Humans
    8. Schneider J, Jaenigen B, Wagner D, Rieg S, Hornuss D, Biever PM, Kern WV, Walz G. Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients. PLoS One. 2021; 16(5):e0249760. PMID: 33974624.
      Citations:    Fields:    Translation:Humans
    9. Rieder M, Wirth L, Pollmeier L, Jeserich M, Goller I, Baldus N, Schmid B, Busch HJ, Hofmann M, Thimme R, Rieg S, Kern W, Bode C, Duerschmied D, Lother A. Serum Protein Profiling Reveals a Specific Upregulation of the Immunomodulatory Protein Progranulin in Coronavirus Disease 2019. J Infect Dis. 2021 03 03; 223(5):775-784. PMID: 33249471.
      Citations: 5     Fields:    Translation:HumansCells
    10. Huber MK, Raichle C, Lingor P, Synofzik M, Borgmann S, Erber J, Tometten L, Rimili W, Dolff S, Wille K, Knauss S, Piepel C, Lanznaster J, Rieg S, Prasser F, Pilgram L, Spottke A, Klockgether T, Klein C, Hopfner F, Höglinger GU. Outcomes of SARS-CoV-2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort. Mov Disord. 2021 04; 36(4):791-793. PMID: 33638915.
      Citations: 2     Fields:    Translation:Humans
    11. Spinner CD, Barton J, Biever P, Klein M, Rieg S, Schneider J, Thoden J, Wagner D, Kern WV. [Steroids in infection medicine]. Dtsch Med Wochenschr. 2021 Feb; 146(3):162-166. PMID: 33513649.
      Citations:    Fields:    Translation:Humans
    12. Cremer S, Jakob C, Berkowitsch A, Borgmann S, Pilgram L, Tometten L, Classen A, Wille K, Weidlich S, Gruener B, Dimmeler S, Massberg S, Rieg S, Zeiher AM. Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry. Clin Res Cardiol. 2021 Jul; 110(7):1029-1040. PMID: 33211155.
      Citations: 6     Fields:    Translation:Humans
    13. Arnold F, Westermann L, Rieg S, Neumann-Haefelin E, Biever PM, Walz G, Kalbhenn J, Tanriver Y. Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study. BMC Nephrol. 2020 11 16; 21(1):486. PMID: 33198670.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    14. Rieg S, von Cube M, Kalbhenn J, Utzolino S, Pernice K, Bechet L, Baur J, Lang CN, Wagner D, Wolkewitz M, Kern WV, Biever P. COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany. PLoS One. 2020; 15(11):e0242127. PMID: 33180830.
      Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
    15. Citations: 77     Fields:    Translation:HumansCells
    16. Citations: 21     Fields:    Translation:HumansPHPublic Health
    17. Shoumariyeh K, Biavasco F, Ihorst G, Rieg S, Nieters A, Kern WV, Miething C, Duyster J, Engelhardt M, Bertz H. Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany. Cancer Med. 2020 11; 9(22):8412-8422. PMID: 32931637.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    18. Luxenburger H, Sturm L, Biever P, Rieg S, Duerschmied D, Schultheiss M, Schultheiss M, Neumann-Haefelin C, Thimme R, Bettinger D. Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor? J Intern Med. 2021 01; 289(1):121-124. PMID: 32608546.
      Citations: 22     Fields:    Translation:HumansPHPublic Health
    19. Kern WV, Biever PM, Rieg S, Panning M. [SARS-CoV-2 infection (COVID-19): what can we expect?] Dtsch Med Wochenschr. 2020 Jun; 145(11):740-746. PMID: 32492743.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    20. Hornuss D, Lange B, Schröter N, Rieg S, Kern WV, Wagner D. Anosmia in COVID-19 patients. Clin Microbiol Infect. 2020 10; 26(10):1426-1427. PMID: 32447049.
      Citations: 47     Fields:    Translation:HumansCellsPHPublic Health
    21. Rieg S, Busch HJ, Hans F, Grundmann H, Biever P, Bürkle H, Hammer T, Thimme R, Kern W. [COVID-19-Response - Strategies of the Task-Force Coronavirus and experiences upon implementation in the management of 115 cases at the University Medical Center Freiburg]. Dtsch Med Wochenschr. 2020 05; 145(10):657-664. PMID: 32344439.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    Rieg's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (194)
    Explore
    _
    Co-Authors (256)
    Explore
    _
    Similar People (60)
    Explore
    _